Additionally, the expression of MBNL1-AS1 is decreased in NSCLC tissues compared to adjacent tissues and upregulation of MBNL1-AS1 could inhibit the proliferation of NSCLC cancer stem cell in vitro and xenograft tumor formation in vivo via miR-301b-3p/transforming growth factor β receptor 2 (TGFBR2) axis (Li et al., 2019b). The gene discussed is MBNL1; the disease is neoplasm.